168 related articles for article (PubMed ID: 17639507)
21. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
22. Prospective identification of tumorigenic prostate cancer stem cells.
Collins AT; Berry PA; Hyde C; Stower MJ; Maitland NJ
Cancer Res; 2005 Dec; 65(23):10946-51. PubMed ID: 16322242
[TBL] [Abstract][Full Text] [Related]
23. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
[TBL] [Abstract][Full Text] [Related]
24. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
Goodyear SM; Amatangelo MD; Stearns ME
Prostate; 2009 May; 69(7):689-98. PubMed ID: 19143028
[TBL] [Abstract][Full Text] [Related]
25. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
[TBL] [Abstract][Full Text] [Related]
26. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.
Mimeault M; Johansson SL; Batra SK
PLoS One; 2012; 7(2):e31919. PubMed ID: 22384099
[TBL] [Abstract][Full Text] [Related]
27. Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial model.
Drewa T; Styczynski J
Int Urol Nephrol; 2007; 39(3):851-7. PubMed ID: 17318344
[TBL] [Abstract][Full Text] [Related]
28. Sca+CD34- murine side population cells are highly enriched for primitive stem cells.
Parmar K; Sauk-Schubert C; Burdick D; Handley M; Mauch P
Exp Hematol; 2003 Mar; 31(3):244-50. PubMed ID: 12644022
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Human Pancreas Side Population as a Potential Reservoir of Adult Stem Cells.
Augstein P; Loudovaris T; Bandala-Sanchez E; Heinke P; Naselli G; Lee L; Hawthorne WJ; Góñez LJ; Neale AM; Vaillant F; Thomas HE; Kay TW; Banakh I; Harrison LC
Pancreas; 2018 Jan; 47(1):25-34. PubMed ID: 29135679
[TBL] [Abstract][Full Text] [Related]
30. The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.
Ceder JA; Jansson L; Ehrnström RA; Rönnstrand L; Abrahamsson PA
Eur Urol; 2008 Mar; 53(3):524-31. PubMed ID: 18053634
[TBL] [Abstract][Full Text] [Related]
31. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
[TBL] [Abstract][Full Text] [Related]
32. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
33. Genotypic and phenotypic characterization of side population of gastric cancer cell lines.
Schmuck R; Warneke V; Behrens HM; Simon E; Weichert W; Röcken C
Am J Pathol; 2011 Apr; 178(4):1792-804. PubMed ID: 21435459
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
[TBL] [Abstract][Full Text] [Related]
35. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.
Petkova N; Hennenlotter J; Sobiesiak M; Todenhöfer T; Scharpf M; Stenzl A; Bühring HJ; Schwentner C
Prostate; 2013 Oct; 73(14):1576-90. PubMed ID: 23836489
[TBL] [Abstract][Full Text] [Related]
36. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
37. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
Harper LJ; Piper K; Common J; Fortune F; Mackenzie IC
J Oral Pathol Med; 2007 Nov; 36(10):594-603. PubMed ID: 17944752
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
[TBL] [Abstract][Full Text] [Related]
39. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
40. Replacing Hoechst33342 with rhodamine123 in isolation of cancer stem-like cells from the MHCC97 cell line.
Liu WH; Qian NS; Li R; Dou KF
Toxicol In Vitro; 2010 Mar; 24(2):538-45. PubMed ID: 19913610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
